Spinal Cord Stimulators (SCS) - Medical Devices Pipeline Assessment, 2019

Table of Contents

• 1.1 List of Tables 5
• 1.2 List of Figures 9

2 Introduction 10

• 2.1 Spinal Cord Stimulators (SCS) Overview 10

3 Products under Development 11

• 3.1 Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development 11
• 3.2 Spinal Cord Stimulators (SCS) - Pipeline Products by Territory 12
• 3.3 Spinal Cord Stimulators (SCS) - Pipeline Products by Regulatory Path 13
• 3.4 Spinal Cord Stimulators (SCS) - Pipeline Products by Estimated Approval Date 14
• 3.5 Spinal Cord Stimulators (SCS) - Ongoing Clinical Trials 15

4 Spinal Cord Stimulators (SCS) - Pipeline Products under Development by Companies 16

• 4.1 Spinal Cord Stimulators (SCS) Companies - Pipeline Products by Stage of Development 16
• 4.2 Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development 17

5 Spinal Cord Stimulators (SCS) Companies and Product Overview 19

• 5.1 Boston Scientific Corp Company Overview 19
  • 5.1.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 19
• 5.2 Cerevast Therapeutics Inc Company Overview 20
  • 5.2.1 Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 20
• 5.3 Direct Spinal Therapeutics, Inc. Company Overview 21
  • 5.3.1 Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
• 5.4 Duke University Company Overview 22
  • 5.4.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 22
• 5.5 GTX Medical BV Company Overview 23
  • 5.5.1 GTX Medical BV Pipeline Products & Ongoing Clinical Trials Overview 23
• 5.6 Imperial College London Company Overview 29
  • 5.6.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 29
• 5.7 Lawson Health Research Institute Company Overview 30
  • 5.7.1 Lawson Health Research Institute Pipeline Products & Ongoing Clinical Trials Overview 30
• 5.8 Meagan Medical Inc. Company Overview 31
  • 5.8.1 Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
• 5.9 Medtronic plc Company Overview 34
  • 5.9.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 34
• 5.10 Micro-Leads Inc Company Overview 37
  • 5.10.1 Micro-Leads Inc Pipeline Products & Ongoing Clinical Trials Overview 37
• 5.11 MicroTransponder Inc Company Overview 39
  • 5.11.1 MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview 39
• 5.12 Neuronoff Inc Company Overview 40
  • 5.12.1 Neuronoff Inc Pipeline Products & Ongoing Clinical Trials Overview 40
• 5.13 Nevro Corp Company Overview 41
  • 5.13.1 Nevro Corp Pipeline Products & Ongoing Clinical Trials Overview 41
• 5.14 Nexstim Plc Company Overview 60
  • 5.14.1 Nexstim Plc Pipeline Products & Ongoing Clinical Trials Overview 60
• 5.15 Nuvectra Corp Company Overview 61
  • 5.15.1 Nuvectra Corp Pipeline Products & Ongoing Clinical Trials Overview 61
• 5.16 Saluda Medical Pty Ltd Company Overview 62
  • 5.16.1 Saluda Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 62
• 5.17 Soterix Medical Inc Company Overview 65
  • 5.17.1 Soterix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 65
• 5.18 SpineX Company Overview 72
  • 5.18.1 SpineX Pipeline Products & Ongoing Clinical Trials Overview 72
• 5.19 St. Jude Medical LLC Company Overview 73
  • 5.19.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 73
• 5.20 University of California Los Angeles Company Overview 77
  • 5.20.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 77
• 5.21 University of Minnesota Company Overview 79
  • 5.21.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 79
• 5.22 Wavegate Technologies LLC Company Overview 82
  • 5.22.1 Wavegate Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 82
• 5.23 WISE s.r.l. Company Overview 83
  • 5.23.1 WISE s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 83

6 Spinal Cord Stimulators (SCS)- Recent Developments 84

• 6.1 Nov 25, 2019: Stimwave Technologies halts commercialization of product line in Australia 84
• 6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 84
• 6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 86
• 6.4 Nov 12, 2019: Nuvectra continuing to support current patients with the Algovita Implant as company voluntarily files for chapter 11 88
• 6.5 Nov 08, 2019: University of Wisconsin Madison: Injectable, flexible electrode could replace rigid nerve-stimulating implants 88

7 Appendix 149

• 7.1 Methodology 149
• 7.2 About GlobalData 152
• 7.3 Contact Us 152